so let's take this on, let's bring in dr. ronald peterson, his neurologist and the director of the outside disease research center at the mayor clinic and joined us by seam from rochester in minnesota in the united states . dr. peterson. so 1st of all, if you would just tell us about this drug, what it does and why it presents hope for suffers a valentine's. thanks for having me, nick. by all means. so had you can't imagine is monoclonal antibody, which when injected into the veins, circulation the blood goes into the brain and removes the amyloid plaque from the brain. tumors. disease is defined by the presence of amyloid plaques in the brain and towel base tangles in the brain. so this remove this drug removes one of the capital logical elements of the disease. the controversy surrounding the drug however, is, does not make a difference, doesn't produce a clinical impact on the patients. right? and even the f d, a said is any, seems reasonably likely to benefit out time as patients and many experts morning that green lighting the drug could, could set a dangerous precedent. well, it's tr